Financial Results

Key highlights

Filter

Period

Filter by

recent search

Showing: 105 of 24 Financial Results


Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:





Your dedicated contacts